AML patients also showed upregulated expression of CD39 (Figure 1F) on B, NK, and CD4+ T cells, which indicates their exhaustion or immunosuppressive function [21,22,23,24]. This evidence concerns the gene ENTPD1 and acute myeloid leukemia.